Blue Owl Capital Holdings LP 13D and 13G filings for Pliant Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:05 pm Unchanged | 2024-09-30 | 13G | Pliant Therapeutics, Inc. PLRX | Blue Owl Capital Holdings LP | 3,004,199 4.940% | 0 (Unchanged) | Filing |
| 2024-02-14 8:55 pm Purchase | 2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Blue Owl Capital Holdings LP | 3,004,199 5.020% | 3,004,199 (New Position) | Filing |